BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9067409)

  • 1. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
    Vihko KK; Seppänen M; Henttinen T; Punnonen J; Grénman S; Punnonen R
    Cancer Immunol Immunother; 1997 Jan; 43(6):368-74. PubMed ID: 9067409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of transcription factor NF-kappaB by growth inhibitory cytokines in vulvar carcinoma cells.
    Seppänen M; Vihko KK
    Immunol Lett; 2000 Oct; 74(2):103-9. PubMed ID: 10996384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
    Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators.
    Seppänen M; Henttinen T; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK
    Oncol Res; 1998; 10(11-12):575-89. PubMed ID: 10367939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-kappaB.
    Seppänen M; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK
    Eur J Endocrinol; 2000 Apr; 142(4):393-401. PubMed ID: 10754482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
    Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
    Pekkola-Heino K; Kulmala J; Grenman S; Carey TE; Grenman R
    Cancer Res; 1989 Sep; 49(17):4876-8. PubMed ID: 2758419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis.
    Seppänen M; Lin L; Saarinen R; Punnonen R; Vihko KK
    Acta Obstet Gynecol Scand; 2008; 87(9):902-9. PubMed ID: 18720042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry.
    Raitanen M; Worsham MJ; Lakkala T; Carey TE; Van Dyke DL; Grénman R; Klemi P; Rantanen V; Isola J; Grénman S
    Gynecol Oncol; 2004 Apr; 93(1):155-63. PubMed ID: 15047230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
    Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
    Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UCI-VULV-1, a vulvar squamous carcinoma cell line.
    Carpenter PM; Gamboa-Vujicic G; Mascarello JT; Wilczynski S; Bhaumik M; Dorion G; Manetta A
    Gynecol Oncol; 1995 May; 57(2):191-8. PubMed ID: 7729733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha-induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor.
    Quentmeier H; Dirks WG; Fleckenstein D; Zaborski M; Drexler HG
    Exp Hematol; 2000 Sep; 28(9):1008-15. PubMed ID: 11008013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
    Carter A; Silvian-Draxler I; Tatarsky I
    Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.